Pamela P. Palmer, MD, Ph.D.

AIMBE College of Fellows Class of 2019
For inventing, developing and commercializing innovative products for the treatment of acute pain.

Pamela Palmer, MD, Ph.D., Has Developed a New Wonder Drug for her Company

Via The Wall Street Transcript | October 10, 2019

Pamela P. Palmer, M.D., Ph.D., has been Chief Medical Officer and Co-Founder of AcelRx Pharmaceuticals, Inc. since she co-founded the company in July 2005. Earlier, she was an anesthesiologist at University California San Francisco — UCSF.

She was director of the UCSF Pain Center for Advanced Research and Education — PainCARE — between 2005 and 2009. The American Pain Society named the UCSF Pain Management Center and PainCARE jointly as one of only six centers of excellence nationwide… Continue reading.

Dr. Pamela Palmer Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 28, 2019

WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Pamela P. Palmer, MD, Ph.D., Co-Founder & Chief Medical Officer, AcelRx Pharmaceuticals, Inc., to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Palmer was nominated, reviewed, and elected by peers and members of the College of Fellows for “inventing, developing and commercializing innovative products for the treatment of acute pain.”